Home> Products> tumor size

{ "products": [ { "_id": "6943af86161ad9de85f42b10", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "imatinib 400mg", "description": "IMATIFLOW 400, containing Imatinib IP 400mg, represents a breakthrough in targeted cancer therapy, offering patients a precise weapon against specific malignancies. This oral medication belongs to the class of tyrosine kinase inhibitors, revolutionizing treatment for conditions once deemed challenging to manage. By blocking abnormal proteins that fuel cancer cell growth, IMATIFLOW 400 helps restore normal cellular function and improves quality of life for many users.​\n\nProduct Overview\nIMATIFLOW 400 is a branded formulation of Imatinib mesylate 400mg, produced to high pharmaceutical standards for consistent efficacy and bioavailability. Each tablet delivers the active ingredient in a film-coated form, designed for once-daily administration with food to enhance absorption and minimize gastrointestinal upset. Developed for adult patients, it targets cancers driven by dysregulated tyrosine kinases like BCR-ABL, c-KIT, and PDGFR, making it a cornerstone in modern oncology protocols.​\n\nThe medication's mechanism hinges on competitive inhibition at the ATP-binding site of these kinases, halting downstream signaling pathways that promote uncontrolled proliferation, survival, and metastasis of malignant cells. Unlike traditional chemotherapy, which broadly attacks dividing cells, IMATIFLOW 400 spares most healthy tissues, leading to a more favorable safety profile. Clinical data from pivotal trials underscore its role as first-line therapy, with high response rates observed within months of initiation.​\n\nPrimary Uses\nIMATIFLOW 400 excels in treating chronic myeloid leukemia (CML), particularly in the chronic phase where it induces deep molecular responses in over 80% of patients. It suppresses the Philadelphia chromosome-positive cells hallmark of CML by inhibiting the BCR-ABL fusion protein, dramatically extending progression-free survival. For newly diagnosed patients, standard dosing starts at 400mg daily, often achieving complete cytogenetic remission.​\n\nIn gastrointestinal stromal tumors (GIST), IMATIFLOW 400 targets KIT or PDGFRA mutations, shrinking unresectable tumors and delaying progression in advanced cases. The recommended dose remains 400mg once daily, with potential escalation to 600-800mg for resistant strains, as per oncology guidelines. It also finds application in dermatofibrosarcoma protuberans (DFSP), aggressive systemic mastocytosis, and certain myelodysplastic syndromes, broadening its utility in precision medicine.​\n\nHealthcare providers monitor response via PCR for BCR-ABL transcripts in CML or imaging for GIST, adjusting therapy based on milestones like major molecular response. Patients with Ph+ acute lymphoblastic leukemia (ALL) may receive it adjunctively, enhancing outcomes when combined with chemotherapy. Overall, IMATIFLOW 400 transforms these diseases from fatal to chronically manageable.​\n\nKey Benefits\nOne standout benefit of IMATIFLOW 400 is its oral convenience, eliminating the need for frequent hospital visits associated with infusions. Response rates exceed 90% in early CML, with many patients achieving treatment-free remission after sustained deep responses, a paradigm shift from interferon-era therapies.​\n\nTumor control in GIST prevents life-threatening complications like bowel obstruction, improving survival from months to years. Its specificity reduces severe toxicities, allowing patients to maintain daily activities, work, and social engagements with minimal disruption. Long-term studies report 10-year survival rates above 80% in CML, underscoring durable efficacy.​\n\nAdditional advantages include cost-effectiveness over biologics and compatibility with supportive care like hydroxyurea for cytoreduction. Fluid retention, while common, responds well to diuretics, preserving cardiac function. For Indian patients, accessible pricing via brands like IMATIFLOW 400 supports equitable care in resource-limited settings.​\n\nPotential Side Effects\nWhile generally well-tolerated, IMATIFLOW 400 can cause edema (swelling in legs or face) in up to 70% of users, managed by dose reduction or supportive measures. Gastrointestinal issues like nausea, vomiting, and diarrhea affect 40-50%, often resolving with antiemetics and dietary adjustments.​\n\nMusculoskeletal pain, cramps, and fatigue occur frequently, alongside rash and abdominal discomfort. Hematologic effects include neutropenia or thrombocytopenia, necessitating regular blood counts. Rare but serious risks involve liver enzyme elevation, heart failure, or hemorrhage; prompt reporting of symptoms like shortness of breath or yellowing skin is crucial.​\n\nAvoid grapefruit juice, as it elevates drug levels, and inform doctors of concurrent medications like CYP3A4 inhibitors. Pregnancy category D status advises contraception, with monitoring for growth retardation in exposed fetuses. Dizziness may impair driving, so caution is essential during initial weeks.​\n\nDosage and Administration Guidelines\nSwallow IMATIFLOW 400 whole with a meal and full glass of water to optimize pharmacokinetics and reduce esophageal irritation. The standard adult dose for CML chronic phase is 400mg daily; for accelerated phase or blast crisis, 600mg. GIST dosing mirrors 400mg, titrated based on tolerance and response.​\n\nRenal or hepatic impairment requires dose adjustments—reduce to 300-400mg in moderate cases. Do not crush or chew tablets. Missed doses should be taken promptly unless near the next, avoiding doubles. Long-term use demands quarterly monitoring of CBC, liver function, and ECG.​\n\nPrecautions and Interactions\nPatients with a cardiac history need baseline echocardiograms, as QT prolongation or effusion risks exist. Drug interactions abound: St. John's wort induces metabolism, reducing efficacy; ketoconazole boosts levels. Vaccines, especially live ones, are contraindicated during therapy.​\n\nRegular dermatologic checks mitigate skin cancer risk from prolonged use. Hydration combats fluid retention, and low-salt diets aid management. Steris Healthcare emphasizes patient education via counseling on adherence for optimal outcomes.​\n\nConclusion\nIMATIFLOW 400 (Imatinib IP 400mg) stands as a testament to targeted therapy's power, offering robust control over CML, GIST, and related cancers with a balance of efficacy and manageability. Its benefits in prolonging life and enhancing daily functioning far outweigh transient side effects for most when monitored diligently. Consult oncologists for personalized plans, ensuring this innovative treatment maximizes hope and health in the fight against cancer.", "price": 1827.0, "discountamount": 540.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2249, "imageuri": "https://productimages.withfloats.com/actual/6943b026ca1b0dcfc6c37820.png", "tileimageuri": "https://productimages.withfloats.com/tile/6943b026ca1b0dcfc6c37820.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-18T07:38:46.766Z", "updatedon": "2026-01-08T07:15:13.88Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/imatinib-400mg/2249", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "IMATIFLOW 400", "category": "NEPHROLOGYRANGE", "tags": [ "Imatinib IP 400mg", "offering robust control over CML.", "related cancers with a balance of efficacy and manageability.", "innovative treatment maximizes hope and health in the fight against cancer.", "cancer therapy.", "fuel cancer cell growth.", "chemotherapy.", "imatinib 400mg.", "imatinib 400mg tablet.", "tab. imatinib 400mg.", "imatinib 400mg price.", "imatinib 400mg tab", "imatinib 400mg side effects.", "imatinib 400 mg tablet", "imatinib 400 mg medicine", "imatinib tablets 400 mg uses", "imatinib 400 mg dosage", "imatinib 400 mg price in india", "imatinib 400 mg brand name" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6662e74687f0960e14a2d95a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Gefitinib 250mg", "description": "\n\nGEFISTERIS 250 is a premium pharmaceutical formulation containing Gefitinib 250mg, a breakthrough targeted therapy medication manufactured by Steris Healthcare. This innovative oral medication represents a significant advancement in the treatment of non-small cell lung cancer (NSCLC), offering patients a precise, scientifically-designed approach to combating one of the world's most challenging malignancies. GEFISTERIS 250 is specifically engineered to target the underlying molecular mechanisms that drive certain types of lung cancer, providing hope and extended survival for patients who carry specific genetic mutations.\nAs a tyrosine kinase inhibitor, GEFISTERIS 250 works at the cellular level to interrupt the signals that tell cancer cells to grow and divide. This targeted approach differs fundamentally from traditional chemotherapy, which affects both healthy and cancerous cells. By focusing specifically on cancer cells with epidermal growth factor receptor (EGFR) mutations, GEFISTERIS 250 offers a more refined treatment strategy with potentially fewer systemic side effects and improved quality of life during treatment.\nUnderstanding Gefitinib 250mg: The Science Behind GEFISTERIS 250\nGefitinib 250mg, the active pharmaceutical ingredient in GEFISTERIS 250, belongs to a revolutionary class of medications known as epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs). The development of this medication marked a paradigm shift in oncology, moving from one-size-fits-all chemotherapy approaches to personalized, mutation-specific treatments.\nThe EGFR protein is found on the surface of cells and plays a crucial role in cell growth and division. In normal cells, EGFR activation is carefully regulated. However, in certain lung cancers, mutations in the EGFR gene cause the receptor to remain constantly active, sending continuous signals for the cell to grow, divide, and survive—leading to uncontrolled cancer growth. GEFISTERIS 250 works by blocking the tyrosine kinase activity of the mutated EGFR protein, effectively turning off the growth signal and causing cancer cells to stop proliferating and eventually die.\nThis precision targeting is what makes GEFISTERIS 250 particularly effective for patients whose tumors harbor activating EGFR mutations, particularly the common exon 19 deletions or exon 21 L858R substitution mutations. Before initiating treatment with GEFISTERIS 250, patients undergo molecular testing to confirm the presence of these mutations, ensuring that the therapy is appropriately matched to their specific cancer biology.\nPrimary Uses and Indications of GEFISTERIS 250\nGEFISTERIS 250 is primarily indicated for the treatment of adult patients with metastatic non-small cell lung cancer whose tumors have specific EGFR mutations. The medication is approved for both first-line treatment in newly diagnosed patients and for those whose disease has progressed after platinum-based chemotherapy.\nFirst-Line Treatment: When EGFR mutations are detected in treatment-naïve patients, GEFISTERIS 250 offers an excellent first-line option, often providing superior progression-free survival compared to traditional chemotherapy regimens. Patients starting with targeted therapy typically experience better tolerability and quality of life during initial treatment phases.\nSecond-Line and Beyond: For patients whose cancer has progressed after chemotherapy, GEFISTERIS 250 provides an effective alternative treatment option, particularly when EGFR mutation testing was not performed initially or when the mutation status was unknown at the time of first treatment.\nThe medication is taken orally as a once-daily tablet, offering significant convenience compared to intravenous chemotherapy that requires hospital visits and lengthy infusion times. This oral administration allows patients to maintain greater independence and normalcy in their daily lives while receiving effective cancer treatment.\nKey Benefits of GEFISTERIS 250\n1. Targeted Cancer Fighting Action\nThe primary benefit of GEFISTERIS 250 lies in its precision targeting mechanism. Unlike conventional chemotherapy that attacks all rapidly dividing cells in the body, GEFISTERIS 250 specifically targets cancer cells bearing EGFR mutations. This selective action means that healthy cells are largely spared, resulting in a more favorable side effect profile and better preservation of normal bodily functions during treatment.\n2. Superior Efficacy in EGFR-Mutant NSCLC\nClinical trials have consistently demonstrated that GEFISTERIS 250 and other EGFR-TKIs provide superior progression-free survival compared to chemotherapy in patients with EGFR-mutant NSCLC. Response rates typically range from 60-80% in appropriate patient populations, with many patients experiencing significant tumor shrinkage and symptomatic improvement within weeks of starting treatment.\n3. Improved Quality of Life\nPatients taking GEFISTERIS 250 often report better quality of life compared to those receiving traditional chemotherapy. The medication's targeted nature results in fewer debilitating side effects such as severe nausea, hair loss, and profound fatigue. Many patients can continue working, traveling, and engaging in normal daily activities while on treatment.\n4. Convenient Oral Administration\nGEFISTERIS 250's once-daily oral dosing eliminates the need for frequent hospital visits for intravenous chemotherapy infusions. Patients take one tablet daily at home, providing tremendous convenience and reducing the burden of treatment. This ease of administration contributes significantly to treatment adherence and patient satisfaction.\n5. Rapid Symptom Relief\nMany patients experience rapid improvement in cancer-related symptoms such as cough, shortness of breath, chest pain, and fatigue within the first few weeks of GEFISTERIS 250 treatment. This quick symptomatic relief can dramatically improve quality of life even before significant tumor shrinkage is visible on imaging studies.\n6. Extended Survival Benefits\nLong-term data demonstrates that appropriate use of EGFR-TKIs like GEFISTERIS 250 contributes to extended overall survival in patients with EGFR-mutant lung cancer. When used as part of a comprehensive treatment strategy, including potential sequential therapies after progression, patients can achieve survival times that were unimaginable before the advent of targeted therapies.\n7. Manageable Side Effect Profile\nWhile GEFISTERIS 250 does cause side effects, they are generally more manageable than those associated with traditional chemotherapy. Most side effects can be effectively controlled with supportive medications, dose modifications, or temporary treatment interruptions, allowing patients to continue benefiting from therapy.\n8. Quality Manufacturing by Steris Healthcare\nGEFISTERIS 250 benefits from Steris Healthcare's commitment to pharmaceutical excellence. Each tablet undergoes rigorous quality testing to ensure consistent potency, purity, and bioavailability. This quality assurance means patients receive reliable, effective medication with every dose.\nSide Effects of GEFISTERIS 250 (Gefitinib 250mg)\nWhile GEFISTERIS 250 offers significant therapeutic benefits, patients should be aware of potential side effects. Understanding these effects enables early recognition and appropriate management.\nCommon Side Effects (Affecting 20% or More of Patients):\nSkin Reactions: The most characteristic side effect of GEFISTERIS 250 is an acne-like rash, typically appearing on the face, chest, and back within the first few weeks of treatment. This rash, while cosmetically concerning for some patients, actually correlates with better treatment response. The rash can be managed with topical antibiotics, moisturizers, and sun protection. In severe cases, temporary dose reduction may be necessary.\nDiarrhea: Approximately 50-60% of patients experience diarrhea of varying severity. Mild diarrhea can often be managed with dietary modifications and over-the-counter anti-diarrheal medications like loperamide. Patients should stay well-hydrated and contact their healthcare provider if diarrhea becomes severe or persistent, as dose adjustments may be needed.\nNail Changes: Some patients develop paronychia (nail bed inflammation) or other nail abnormalities. Proper nail care, avoiding trauma to the nail beds, and wearing protective gloves during housework can help minimize these effects.\nDry Skin: Many patients experience skin dryness and itching. Regular use of fragrance-free moisturizers, gentle cleansers, and avoidance of hot showers can help manage these symptoms.\nMouth Sores: Oral mucositis or stomatitis can develop in some patients. Good oral hygiene, avoiding spicy or acidic foods, and using alcohol-free mouthwashes can provide relief.\nLess Common but Serious Side Effects:\nInterstitial Lung Disease (ILD): While rare (1-2% of patients), ILD is the most serious potential side effect of GEFISTERIS 250. Symptoms include sudden onset or worsening of respiratory symptoms such as difficulty breathing, cough, or fever. This requires immediate medical attention and usually necessitates permanent discontinuation of the medication.\nLiver Function Abnormalities: Elevated liver enzymes can occur, requiring regular monitoring through blood tests. Most cases are asymptomatic and reversible with dose modification or temporary discontinuation.\nEye Problems: Dry eyes, corneal erosion, or other ocular issues may develop. Regular use of lubricating eye drops and ophthalmological evaluation when symptoms occur can prevent serious complications.\nGastrointestinal Perforation: Though rare, serious gastrointestinal complications including perforation can occur, particularly in patients with underlying GI conditions.\nManagement Strategies:\nMost side effects can be effectively managed through:\n\nProactive supportive care and prophylactic measures\nDose modifications (reduction to 250mg every other day in some cases)\nTemporary treatment interruptions allowing recovery\nSymptomatic treatment with appropriate medications\nPatient education about early recognition and reporting of symptoms\n\nPatients should maintain open communication with their healthcare team, reporting any new or worsening symptoms promptly. Regular monitoring through clinical visits and laboratory testing helps identify and address side effects before they become serious.\nDosage and Administration Guidelines\nThe standard dose of GEFISTERIS 250 is one 250mg tablet taken orally once daily, with or without food. The tablet should be swallowed whole with water and should not be crushed or chewed. If a dose is missed and it's been less than 12 hours since the scheduled time, patients should take the missed dose. If more than 12 hours have passed, skip the missed dose and resume the regular schedule—never double up on doses.\nTreatment continues until disease progression or unacceptable toxicity occurs. Some patients remain on GEFISTERIS 250 for months or even years if they continue to benefit without prohibitive side effects. Dose modifications may be necessary based on individual tolerance, typically reducing the frequency to every other day rather than lowering the individual dose.\nPrecautions and Important Considerations\nPatients taking GEFISTERIS 250 should be aware of several important precautions. The medication can cause harm to developing fetuses, so women of childbearing potential must use effective contraception during treatment and for at least two weeks after the last dose. Breastfeeding should be avoided during treatment and for two weeks after completion.\nGEFISTERIS 250 can interact with medications that affect stomach acid, including proton pump inhibitors and H2-receptor antagonists. If antacids are needed, they should be taken several hours apart from GEFISTERIS 250. The medication may also interact with certain other drugs metabolized by the liver, so patients should inform their healthcare provider about all medications, supplements, and herbal products they're taking.\nRegular monitoring is essential during GEFISTERIS 250 treatment, including periodic liver function tests, pulmonary symptom assessment, and clinical evaluation for skin and other toxicities. Patients should avoid prolonged sun exposure and use high-SPF sunscreen, as the medication can increase photosensitivity.\nConclusion\nGEFISTERIS 250 represents a transformative treatment option for patients with EGFR-mutant non-small cell lung cancer, offering targeted, effective therapy with a manageable side effect profile. Manufactured by Steris Healthcare with unwavering commitment to quality and patient outcomes, GEFISTERIS 250 delivers Gefitinib 250mg in a formulation designed for optimal bioavailability and consistent therapeutic effect.\nThe medication's precision targeting of cancer-driving mutations, combined with convenient oral administration and generally tolerable side effects, makes GEFISTERIS 250 an excellent choice for eligible patients. While side effects do occur and require monitoring and management, the potential benefits—including tumor response, symptom improvement, extended progression-free survival, and enhanced quality of life—often significantly outweigh the risks for appropriately selected patients.\nSuccess with GEFISTERIS 250 requires partnership between patients and their healthcare teams. Molecular testing to confirm EGFR mutation status before treatment, adherence to the prescribed regimen, proactive management of side effects, and regular monitoring all contribute to optimal outcomes. For many patients with EGFR-mutant lung cancer, GEFISTERIS 250 offers not just treatment, but genuine hope for extended, quality life.\nAs personalized medicine continues to evolve, medications like GEFISTERIS 250 exemplify the power of matching treatments to individual tumor characteristics. Steris Healthcare's commitment to delivering this advanced therapy with assured quality and accessibility ensures that more patients can benefit from the remarkable advances in targeted cancer treatment that Gefitinib 250mg represents.\n", "price": 2760.0, "discountamount": 828.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "food", "Call", "Uses", "Rash", "Note", "NSCLC", "Email", "nausea", "Dosage", "spread", "WhatsApp", "diarrhea", "Gefitinib", "treatment", "One tablet", "GEFISTERIS", "information", "sterispharma", "consultation", "sterisonline", "Side Effects", "cancer cells", "targeted therapy", "Regular monitoring", "healthcare provider", "small cell lung cancer", "healthcare professional", "specific EGFR mutations", "epidermal growth factor receptor", "potential liver function alterations" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1530, "imageuri": "https://productimages.withfloats.com/actual/667d25ffb56721898510e93e.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d25ffb56721898510e93e.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T10:56:06.808Z", "updatedon": "2025-12-24T09:35:26.473Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/gefitinib-250mg/1530", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GEFISTERIS 250", "category": "Oncology", "tags": [ "gefitinib 250 mg uses", "", "gefitinib 250 mg online purchase", "", "gefitinib 250 mg tablets price in india", "non-small cell lung cancer (NSCLC).", "triggered by chemotherapy.", "cancer biology.", "Superior Efficacy in EGFR-Mutant NSCLC" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6662d50f8ecffe165c355141", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "capecitabine 500mg", "description": "CAPECITIME 500 \nCapecitabine lp 500mg\nCAPECITIME 500 represents a significant advancement in the landscape of oncological therapeutics. Manufactured with stringent quality standards by Steris Healthcare, this pharmaceutical product contains Capecitabine IP 500mg, a potent antimetabolite chemotherapy agent. It is designed to offer a balance of high efficacy and patient convenience, shifting the paradigm of cancer care from exclusively hospital-based intravenous treatments to a manageable, home-based oral regimen.\n\nIn the complex battle against malignancy, precision and tolerability are paramount. CAPECITABINE 500 serves as a 'prodrug'—a medication that remains largely inactive until it enters the body. Once ingested, it undergoes a unique three-step enzymatic conversion process, transforming into its active cytotoxic form, 5-fluorouracil (5-FU), preferentially within tumor tissues. This mechanism aims to maximize the destruction of cancer cells while striving to spare healthy tissues, making CAPECITABINE 500 a cornerstone therapy for patients battling colorectal, breast, and gastric cancers.\n\nMechanism of Action: The Science of CAPECITABINE 500\nUnderstanding how CAPECITIME 500 works is essential to appreciating its value. Unlike traditional chemotherapy that attacks all rapidly dividing cells indiscriminately, capecitabine is designed to be smarter.\n\nAbsorption and Conversion: Upon swallowing the CAPECITIME 500 tablet, the drug is absorbed through the intestinal wall. It passes through the liver, where it is converted into an intermediate compound.\n\nTumor Targeting: The final conversion to the active cancer-killing agent, 5-FU, occurs primarily in the presence of an enzyme called thymidine phosphorylase. Research indicates that this enzyme is often found in higher concentrations in tumor tissues compared to normal healthy tissues.\n\nDNA Disruption: Once active inside the cancer cell, the drug mimics essential nutrients the cell needs to grow (specifically inhibiting thymidylate synthase). This effectively 'starves' the cancer cell of the building blocks required for DNA replication and repair, leading to cell death (apoptosis) and slowing tumor progression.\n\nTherapeutic Indications and Uses\nCAPECITABINE 500 is a versatile oncology medication prescribed by specialists for several specific types of cancer. Its efficacy is well-documented in various clinical settings:\n\n1. Colorectal Cancer\nAdjuvant Treatment: CAPECITIME 500 is widely used for patients with Stage III (Dukes' C) colon cancer who have undergone surgery to remove the primary tumor. In this setting, the drug acts as a 'cleanup' agent, targeting any microscopic cancer cells that may remain, significantly reducing the risk of recurrence and improving survival rates.\n\nMetastatic Colorectal Cancer: For cases where the cancer has spread (metastasized) to other parts of the body, CAPECITIME 500 is often the first-line treatment. It can be used as a standalone therapy (monotherapy) or in combination with other chemotherapy agents to control disease progression.\n\n2. Breast Cancer\nAdvanced or Metastatic Disease: CAPECITIME 500 plays a critical role in treating advanced breast cancer. It is frequently prescribed when the cancer has stopped responding to other standard chemotherapy treatments, such as paclitaxel or anthracyclines.\n\nCombination Therapy: It is often paired with other drugs (e.g., docetaxel) to enhance the attack on cancer cells, providing a synergistic effect that can shrink tumors more effectively than single agents alone.\n\n3. Gastric (Stomach) Cancer\nCAPECITABINE 500 is also a key component in the treatment regimen for advanced gastric cancer, often used in combination with platinum-based chemotherapy. It helps in palliative care settings to extend survival and improve the quality of life for patients with inoperable tumors.\n\nKey Benefits of CAPECITIME 500\nPatients and healthcare providers choose CAPECITABINE 500 for several distinct advantages that set it apart from conventional intravenous chemotherapy.\n\n1. Convenience of Oral Administration\nPerhaps the most immediate benefit for the patient is the form factor. Traditional 5-FU treatment requires continuous intravenous (IV) infusion, necessitating frequent hospital visits, catheter lines, or portable pumps. CAPECITIME 500 is a tablet. This allows patients to take their medication in the comfort of their own homes, reducing hospital visits and allowing them to maintain a more normal daily routine, work schedule, and family life.\n\n2. Targeted 'Tumor-Activated' Therapy\nBecause the drug is converted to its active form largely within the tumor site (due to higher enzyme levels there), CAPECITIME 500 achieves high concentrations of medicine exactly where it is needed—inside the cancer. This targeted approach aims to reduce systemic toxicity compared to older chemotherapy methods that flood the entire bloodstream with active toxins.\n\n3. Proven Efficacy & Quality\nManufactured by Steris Healthcare, CAPECITIME 500 adheres to WHO-GMP (Good Manufacturing Practices) standards, ensuring that patients receive a product of high purity, stability, and consistent dosage. Clinical data supports that oral Capecitabine is at least equivalent to intravenous 5-FU in terms of survival outcomes for colorectal cancer, with the added benefit of improved convenience.\n\n4. Flexible Combination Partner\nCAPECITIME 500 is highly versatile. It can be effectively combined with a wide range of other cancer therapies, including radiation therapy and biologic agents, allowing oncologists to tailor treatment plans to the specific genetic makeup and stage of the patient's cancer.\n\nPotential Side Effects and Management\nWhile CAPECITIME 500 is designed to be more targeted, it is still a potent chemotherapy drug, and side effects can occur. Being aware of these helps patients manage them effectively.\n\nCommon Side Effects\nGastrointestinal Issues: Diarrhea, nausea, vomiting, and abdominal pain are common. These are usually manageable with dietary changes and additional medications prescribed by the doctor.\n\nFatigue: A general sense of tiredness or weakness is frequently reported.\n\nHand-Foot Syndrome (Palmar-Plantar Erythrodysesthesia): This is a specific side effect where the palms of the hands and soles of the feet become red, swollen, tender, or peeled. It is caused by small amounts of the drug leaking from capillaries in these areas.\n\nSerious Side Effects (Rare but Important)\nCardiac Symptoms: Rarely, patients may experience chest pain or heart palpitations.\n\nLow Blood Cell Counts: The drug can temporarily lower the number of white blood cells (increasing infection risk), red blood cells (anemia), and platelets (bruising).\n\nSevere Diarrhea: If left untreated, this can lead to dehydration.\n\nManaging Side Effects\nHydration: Patients are advised to drink plenty of fluids.\n\nSkin Care: For Hand-Foot Syndrome, keeping hands and feet moisturized, avoiding tight shoes, and staying away from hot water/heat sources is recommended.\n\nCommunication: Early reporting of side effects to a healthcare provider often allows for dose adjustments that can stop the side effects from becoming severe.\n\nDosage and Administration\nPrescription Only: CAPECITABINE 500 is a prescription-only medicine and must be taken exactly as directed by an oncologist.\n\nTypical Cycle: A common regimen involves taking the tablets twice daily (morning and evening) for 14 consecutive days, followed by a 7-day rest period. This constitutes one 21-day cycle.\n\nWith Food: It is crucial to take CAPECITIME 500 within 30 minutes after a meal with water. Taking it with food reduces the risk of stomach upset and ensures proper absorption.\n\nConclusion\nCAPECITIME 500 (Capecitabine 500mg) stands as a vital therapeutic option in modern oncology. By combining the potency of traditional chemotherapy with the smart science of tumor-enzyme activation, it offers a powerful weapon against colorectal, breast, and gastric cancers.\n\nBeyond its chemical efficacy, CAPECITIME 500 offers the profound benefit of dignity and independence. The ability to self-administer chemotherapy at home empowers patients, reducing the burden of clinical visits and allowing them to focus more on healing and living. With its high-quality formulation by Steris Healthcare, CAPECITIME 500 provides a reliable, effective, and patient-centric solution for cancer management.", "price": 1222.0, "discountamount": 366.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "body", "Call", "blood", "Email", "class", "amount", "nausea", "doctor", "disorder", "WhatsApp", "headache", "CABERGLOW", "dizziness", "conditions", "CAPECITIME", "medication", "infertility", "information", "Capecitabine", "constipation", "instructions", "sterispharma", "sterisonline", "Cabergoline IP", "unusual symptoms", "hyperprolactinemia", "associated symptoms", "Excessive prolactin", "Common side effects", "other related issues", "normal hormone levels", "healthcare professional", "excess prolactin hormone", "dopamine receptor agonists", "irregular menstrual periods" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1525, "imageuri": "https://productimages.withfloats.com/actual/667d2be5cd6f42ac046088e1.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d2be5cd6f42ac046088e1.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T09:38:23.283Z", "updatedon": "2026-02-21T07:11:39.002Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/capecitabine-500mg/1525", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CAPECITIME 500 ", "category": "NEPHROLOGYRANGE", "tags": [ "capecitabine 500 mg tablet price", "capecitabine 500 mg tablet dosage", "capecitabine 500 mg tablet side effects", "CAPECITIME 500", "Capecitabine IP 500mg", "Combination Therapy", "CAPECITIME 500 is a tablet.", "colorectal, breast, and gastric cancers.", "CAPECITIME 500", "5-FU in terms of survival outcomes for colorectal cancer.", "capecitabine 500mg oral chemotherapy tablets", "capecitabine 500mg chemotherapy at home", "capecitabine 500mg for metastatic breast cancer", "buy capecitabine 500mg online", "capecitabine 500mg price per tablet" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6662c47c2bed1f08484d6c10", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TAMOXIFILM 20 ", "description": "TAMOXIFILM 20 \nTamoxifen IP (20mg)\nTamoxifilm 20 contains Tamoxifen IP at a concentration of 20mg per dose. Tamoxifen is a medication commonly used in the treatment of breast cancer. It belongs to a class of drugs known as selective estrogen receptor modulators (SERMs). Tamoxifen works by blocking the effects of estrogen in the breast tissue, thereby slowing down or stopping the growth of cancer cells that require estrogen to grow.\n\nTamoxifilm 20 is typically prescribed for:\n\nBreast Cancer: It is effective in both early-stage and advanced breast cancer cases. It may be used before surgery to reduce tumor size or after surgery to prevent the recurrence of cancer.\n\nPrevention: Tamoxifen is also used for reducing the risk of developing breast cancer in high-risk individuals, especially those with a family history of breast cancer or certain genetic mutations.\n\nHormone Receptor-Positive Breast Cancer: It is particularly beneficial for hormone receptor-positive breast cancers, where the cancer cells have receptors for estrogen or progesterone.\n\nMetastatic Breast Cancer: In cases where breast cancer has spread to other parts of the body, Tamoxifen can help in controlling the spread and managing the symptoms.\n\nUsage and Dosage:\n\nTamoxifilm 20 is usually taken orally, with or without food.\nThe typical dosage for breast cancer treatment is 20mg to 40mg daily, usually for 5 years or as directed by the healthcare provider.\nFor prevention purposes, the dosage may vary depending on individual risk factors and medical history.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nOrder Now: \n\nhttps://www.sterisonline.com/product/tamoxifilm-20-133689", "price": 32.0, "discountamount": 9.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "body", "Call", "dose", "20mg", "40mg", "food", "SERMs", "drugs", "Order", "Usage", "class", "Email", "spread", "growth", "surgery", "effects", "5 years", "WhatsApp", "symptoms", "receptors", "tumor size", "recurrence", "medication", "TAMOXIFILM", "information", "other parts", "early-stage", "sterispharma", "progesterone", "sterisonline", "cancer cells", "Tamoxifen IP", "breast tissue", "concentration", "family history", "typical dosage", "medical history", "genetic mutations", "healthcare provider", "prevention purposes", "high-risk individuals", "breast cancer treatment", "individual risk factors", "Metastatic Breast Cancer", "advanced breast cancer cases", "selective estrogen receptor modulators", "hormone receptor-positive breast cancers" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1511, "imageuri": "https://productimages.withfloats.com/actual/667d3e4b000f6c164f0965cb.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d3e4b000f6c164f0965cb.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T08:27:40.343Z", "updatedon": "2024-06-27T10:26:13.622Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/tamoxifilm-20-/1511", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TAMOXIFILM 20 ", "category": "NEPHROLOGYRANGE", "tags": [ "", "tamoxifen 20 mg uses", "tamoxifen 20 mg dosage", "", "tamoxifen 20 mg side effects", "tamoxifen 20 mg brand name", "tamoxifen 20 mg buy online" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6992dbea1456f45dc237ccde", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "light moisturizing cream", "description": "In the ever-evolving world of skincare, finding the perfect moisturizer that balances effective hydration without overwhelming your skin can feel like searching for a needle in a haystack. Enter Eurosoft Steris LIGHT MOIST CREAM – a revolutionary lightweight moisturizing solution designed to quench your skin's thirst while maintaining that coveted fresh, non-greasy finish that modern skincare enthusiasts demand.Product OverviewEurosoft Steris LIGHT MOIST CREAM represents the perfect marriage between science and nature, formulated specifically for those who want effective moisturization without the heavy, sticky residue traditional creams often leave behind. This advanced dermatological formulation is crafted to provide optimal hydration while respecting your skin's natural balance, making it an ideal choice for daily use across various skin types and climatic conditions.The cream's innovative lightweight texture absorbs rapidly into the skin, delivering essential moisture deep into the dermal layers without clogging pores or creating an uncomfortable film on the surface. Whether you're dealing with the harsh effects of air conditioning, environmental pollutants, or simply the natural moisture loss that occurs throughout the day, Eurosoft Steris LIGHT MOIST CREAM stands as your reliable defense against dehydration and dullness.How to Use Eurosoft Steris LIGHT MOIST CREAMIncorporating this light moisturizer into your daily skincare routine is remarkably simple and straightforward. For optimal results, begin with freshly cleansed skin – this ensures maximum absorption and effectiveness of the active ingredients. Gently pat your face dry with a clean towel, leaving your skin slightly damp to lock in additional moisture.Take a small, pea-sized amount of Eurosoft Steris LIGHT MOIST CREAM onto your fingertips and dot it across your forehead, cheeks, nose, and chin. Using gentle upward and outward circular motions, massage the cream into your skin, paying special attention to areas prone to dryness such as the cheeks and around the eyes. The lightweight formula will absorb within seconds, leaving no greasy residue.For best results, apply the cream twice daily – once in the morning as part of your daytime skincare routine before makeup application, and once at night before bed to support your skin's natural overnight repair processes. During particularly dry seasons or in harsh environmental conditions, you may increase application frequency as needed. The cream is gentle enough for multiple daily applications without causing buildup or congestion.Key Benefits of Eurosoft Steris LIGHT MOIST CREAMLightweight Hydration: The primary advantage of this cream lies in its ability to deliver deep, lasting moisture without the heaviness associated with traditional moisturizers. The fast-absorbing formula penetrates quickly, making it perfect for those who dislike the greasy feeling many creams leave behind.Suitable for All Skin Types: Whether you have oily, combination, dry, or sensitive skin, Eurosoft Steris LIGHT MOIST CREAM adapts to your specific needs. Its balanced formulation doesn't overwhelm oily skin or leave dry skin wanting more, making it a versatile addition to any skincare arsenal.Non-Comedogenic Formula: One of the most significant benefits is its non-pore-clogging properties. Unlike heavier creams that can trap dirt and oil, leading to breakouts and blackheads, this light moisturizer allows your skin to breathe while staying protected and hydrated.Enhanced Skin Barrier Function: Regular use strengthens your skin's natural protective barrier, helping to lock in moisture and shield against environmental aggressors such as pollution, UV rays, and harsh weather conditions. This improved barrier function translates to healthier, more resilient skin over time.Improved Skin Texture and Tone: With consistent application, users often notice a visible improvement in skin texture – rough patches become smoother, fine lines appear diminished, and overall skin tone becomes more even and radiant. The cream helps promote cellular turnover, revealing fresher, more youthful-looking skin.Perfect Makeup Base: The quick-absorbing, non-greasy nature of Eurosoft Steris LIGHT MOIST CREAM makes it an excellent primer for makeup application. It creates a smooth, hydrated canvas that helps foundation glide on effortlessly and last longer throughout the day.Antioxidant Protection: The formulation typically includes antioxidants that help combat free radical damage, one of the primary causes of premature aging. This protective benefit means you're not just moisturizing – you're actively defending your skin against environmental stress.Soothing and Calming: Many users report a calming effect on irritated or sensitive skin. The gentle formulation helps reduce redness and discomfort, making it suitable even for those with reactive skin conditions.Potential Side Effects and PrecautionsWhile Eurosoft Steris LIGHT MOIST CREAM is formulated to be gentle and suitable for most skin types, it's important to be aware of potential side effects, though they are generally rare and mild.Initial Adjustment Period: Some users may experience a brief adjustment period when first introducing the cream to their routine. This might manifest as slight tingling or temporary redness, which typically subsides within a few days as your skin acclimates to the new product.Allergic Reactions: Although uncommon, allergic reactions can occur with any skincare product. Signs may include persistent redness, itching, swelling, or the development of a rash. If you experience any of these symptoms, discontinue use immediately and consult a dermatologist.Increased Sensitivity: In rare cases, individuals with extremely sensitive skin might experience heightened sensitivity to sunlight or certain environmental factors. Always pair your moisturizer with appropriate sun protection during daytime use.Breakouts in Acne-Prone Individuals: While the formula is non-comedogenic, everyone's skin is unique. A small percentage of users with very acne-prone skin might experience minor breakouts initially. This could be a purging phase or an indication that the product isn't suitable for your specific skin chemistry. To minimize the risk of adverse reactions, always perform a patch test before full application. Apply a small amount of the cream to the inside of your wrist or behind your ear and wait 24 hours to check for any negative reactions. Additionally, ensure you're purchasing authentic Eurosoft products from authorized retailers to guarantee quality and safety. Conclusion Eurosoft Steris LIGHT MOIST CREAM emerges as a standout solution in the crowded moisturizer market, offering the perfect balance of effective hydration and comfortable wearability. Its lightweight, fast-absorbing formula addresses the common complaint many have with traditional moisturizers—that heavy, greasy feeling that lingers long after application.", "price": 130.0, "discountamount": 39.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2307, "imageuri": "https://productimages.withfloats.com/actual/699305beab4a9d571bc318cb.png", "tileimageuri": "https://productimages.withfloats.com/tile/699305beab4a9d571bc318cb.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-02-16T08:57:14.969Z", "updatedon": "2026-02-21T05:54:31.286Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/light-moisturizing-cream/2307", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "EUROSOFT LIGHT MOIST CREAM", "category": "DERMATALOGY", "tags": [ "lightweight moisturizing cream for summer", "fragrance free light moisturizing cream for sensitive skin", "light face cream for humid weather", "light moisturizing cream for combination skin", "light moisturizing cream with hyaluronic acid", "aloe vera light moisturizing cream for face", "vitamin C light moisturizing cream", "natural light moisturizing cream without parabens", "dermatologist recommended light moisturizing cream" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6989adebfa5708ebdc6e8eee", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Clindamycin and Nicotinamide gel", "description": "VIGA BRIGHT Gel is an advanced dermatological formulation that combines two powerful active ingredients—Clindamycin and Nicotinamide—to deliver comprehensive acne treatment and skin brightening benefits. This scientifically formulated topical gel represents a breakthrough in skincare technology, addressing multiple skin concerns simultaneously. Designed for individuals struggling with acne, blemishes, hyperpigmentation, and uneven skin tone, VIGA BRIGHT Gel offers a dual-action approach that not only treats existing skin problems but also prevents future breakouts while promoting a naturally luminous complexion.\nThe unique synergy between Clindamycin, a proven antibiotic agent, and Nicotinamide, a form of Vitamin B3 known for its anti-inflammatory and skin-brightening properties, makes VIGA BRIGHT Gel a comprehensive solution for achieving healthier, clearer, and more radiant skin. This dermatologist-recommended formulation is suitable for various skin types and can be seamlessly integrated into daily skincare routines.\nUnderstanding the Active Ingredients\nClindamycin is a lincosamide antibiotic that works by inhibiting bacterial protein synthesis, effectively targeting the Propionibacterium acnes bacteria responsible for inflammatory acne. When applied topically, it penetrates the skin layers to combat bacterial growth at the source, reducing inflammation and preventing new acne lesions from forming.\nNicotinamide, also known as Niacinamide or Vitamin B3, is a water-soluble vitamin with remarkable skin-enhancing properties. It works at the cellular level to improve skin barrier function, reduce inflammation, regulate sebum production, and diminish hyperpigmentation. The combination of these two ingredients in VIGA BRIGHT Gel creates a powerful treatment that addresses acne while simultaneously improving overall skin quality and appearance.\nHow to Use VIGA BRIGHT Gel\nFor optimal results, proper application of VIGA BRIGHT Gel is essential. Begin by thoroughly cleansing your face with a gentle, non-comedogenic cleanser and pat your skin dry with a clean towel. Once your skin is completely dry, take a small amount of VIGA BRIGHT Gel—approximately a pea-sized quantity is sufficient for the entire face—and apply it evenly to the affected areas or as directed by your dermatologist.\nThe gel should be applied in a thin layer, avoiding the immediate eye area, lips, and any broken or irritated skin. Gently massage the gel into your skin using upward, circular motions until it is fully absorbed. For best results, use VIGA BRIGHT Gel once or twice daily, preferably in the evening before bedtime, as this allows the active ingredients to work effectively overnight when skin regeneration is at its peak.\nConsistency is crucial when using VIGA BRIGHT Gel. While some users may notice improvements within two to four weeks, optimal results typically appear after eight to twelve weeks of regular use. Always follow your healthcare provider's instructions regarding frequency and duration of application, and avoid using more product than recommended, as this will not accelerate results and may increase the risk of side effects.\nKey Benefits of VIGA BRIGHT Gel\nEffective Acne Treatment: The Clindamycin component powerfully combats acne-causing bacteria, significantly reducing inflammatory acne lesions including papules, pustules, and nodules. Regular use helps clear existing breakouts and prevents new ones from forming.\nSkin Brightening and Even Tone: Nicotinamide works to inhibit melanin transfer to skin cells, effectively reducing dark spots, post-inflammatory hyperpigmentation, and acne scars. This results in a noticeably brighter, more even-toned complexion over time.\nAnti-Inflammatory Action: Both active ingredients possess anti-inflammatory properties that calm redness, reduce swelling, and soothe irritated skin, making it particularly beneficial for sensitive, acne-prone skin.\nSebum Regulation: Nicotinamide helps regulate excessive oil production, addressing one of the primary causes of acne while preventing pores from becoming clogged with excess sebum.\nImproved Skin Texture: With continued use, VIGA BRIGHT Gel refines skin texture, minimizing the appearance of enlarged pores and creating a smoother, more refined complexion.\nEnhanced Skin Barrier Function: Nicotinamide strengthens the skin's natural protective barrier, improving moisture retention and protecting against environmental aggressors and irritants.\nReduced Acne Scarring: By addressing inflammation early and promoting healthy skin cell turnover, VIGA BRIGHT Gel helps minimize the formation of acne scars and gradually fades existing marks.\nNon-Comedogenic Formula: The gel-based formulation is lightweight and non-greasy, making it suitable for oily and combination skin types without clogging pores or causing additional breakouts.\nPotential Side Effects and Precautions\nWhile VIGA BRIGHT Gel is generally well-tolerated, some users may experience mild side effects, particularly during the initial weeks of use as the skin adjusts to the active ingredients.\nCommon Side Effects may include mild dryness, slight peeling or flaking, temporary redness at application sites, tingling or stinging sensation upon application, and mild itching. These effects are typically temporary and often subside as your skin acclimates to the treatment.\nLess Common Side Effects might involve contact dermatitis, increased skin sensitivity to sunlight, burning sensation, or excessive dryness. If these symptoms persist or worsen, discontinue use and consult your dermatologist.\nImportant Precautions: Always perform a patch test before full application, especially if you have sensitive skin. Apply a small amount to your inner forearm and wait 24 hours to check for adverse reactions. Avoid contact with eyes, mouth, nostrils, and mucous membranes; if accidental contact occurs, rinse thoroughly with water. Use a broad-spectrum sunscreen with SPF 30 or higher during daytime, as the treatment may increase sun sensitivity.\nPregnant or breastfeeding women should consult their healthcare provider before using VIGA BRIGHT Gel. Inform your dermatologist about all medications and skincare products you're currently using to avoid potential interactions. Do not use on broken, wounded, or eczematous skin without medical supervision.\nMaximizing Results with VIGA BRIGHT Gel\nTo achieve the best possible outcomes, incorporate VIGA BRIGHT Gel into a comprehensive skincare routine. Maintain consistency in application, stay hydrated by drinking adequate water throughout the day, and protect your skin from sun exposure with appropriate sunscreen. Avoid using harsh exfoliants or alcohol-based products that may cause additional irritation, and be patient—visible improvements in skin clarity and tone develop gradually with regular use.\nConclusion\nVIGA BRIGHT Gel represents a sophisticated approach to treating acne while simultaneously addressing pigmentation concerns and promoting overall skin health. The intelligent combination of clindamycin and Nicotinamide offers a comprehensive solution for individuals seeking clearer, brighter, and more radiant skin. By targeting acne-causing bacteria, reducing inflammation, regulating oil production, and brightening skin tone, this advanced formulation delivers multiple benefits in a single, convenient product.", "price": 125.0, "discountamount": 38.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2297, "imageuri": "https://productimages.withfloats.com/actual/6989aded9d6c96009e4b0b7d.png", "tileimageuri": "https://productimages.withfloats.com/tile/6989aded9d6c96009e4b0b7d.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-02-09T09:50:35.058Z", "updatedon": "2026-02-09T09:50:35.058Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/clindamycin-and-nicotinamide-gel/2297", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "VIGA BRIGHT Gel", "category": "Dermatology", "tags": [ "clindamycin and nicotinamide gel uses", "clindamycin nicotinamide gel benefits", "clindamycin nicotinamide gel how to use", "clindamycin nicotinamide gel side effects", "clindamycin and nicotinamide gel composition", "clindamycin nicotinamide gel for acne", "clindamycin nicotinamide gel for pimples", "clindamycin nicotinamide gel for acne scars", "clindamycin nicotinamide topical gel", "clindamycin nicotinamide gel 1 percent", "clindamycin nicotinamide gel tube", "what is clindamycin and nicotinamide gel", "is clindamycin nicotinamide gel safe", "how long does clindamycin nicotinamide gel take to work", "who should use clindamycin nicotinamide gel", "clindamycin with nicotinamide gel", "nicotinamide clindamycin acne gel" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69662101a96bbf383231d700", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "FABRICAL MG K₂7", "description": "FABRICAL MG K₂7 represents a scientifically advanced nutritional supplement that combines essential minerals and vitamins in a synergistic formulation designed to support optimal bone health, cardiovascular function, and overall metabolic wellness. This innovative product brings together six critical nutrients—Calcium Citrate Maleate, Magnesium Bisglycinate, Vitamin D3, Vitamin K2-7 (Menaquinone-7), Zinc, and Methylcobalamin—in precise therapeutic ratios that maximize bioavailability and clinical effectiveness.\nUnlike conventional calcium supplements that focus solely on calcium supplementation, FABRICAL MG K₂7 adopts a comprehensive, multi-nutrient approach that addresses the complex interplay between various micronutrients essential for skeletal integrity, neuromuscular function, immune competence, and metabolic regulation. This sophisticated formulation reflects current understanding of nutritional biochemistry, recognizing that optimal health outcomes require balanced supplementation rather than isolated nutrient provision.\nThe product has been meticulously formulated to address the growing epidemic of nutritional deficiencies affecting diverse populations, from elderly individuals experiencing age-related bone loss to young adults with suboptimal dietary intake, pregnant women with increased nutritional demands, and individuals with chronic conditions affecting nutrient absorption or utilization. FABRICAL MG K₂7 serves as a convenient, evidence-based solution for maintaining nutritional adequacy and supporting long-term health across various life stages.\nDetailed Understanding of FABRICAL MG K₂7 Components\nCalcium Citrate Maleate: Superior Calcium Bioavailability\nCalcium Citrate Maleate represents the premium form of calcium supplementation, offering significantly enhanced absorption compared to traditional calcium carbonate. This advanced calcium complex demonstrates approximately 25-30% better bioavailability, making it particularly valuable for individuals with reduced gastric acid production, including elderly populations and those taking proton pump inhibitors or H2-receptor antagonists. Unlike calcium carbonate, which requires acidic conditions for optimal dissolution, Calcium Citrate Maleate can be absorbed efficiently regardless of meal timing or stomach pH, providing greater flexibility and convenience.\nThe maleate component further enhances calcium absorption and utilization by supporting cellular energy metabolism and mitochondrial function. This sophisticated formulation ensures that supplemented calcium reaches target tissues—bones, teeth, muscles, and nerves—where it performs essential physiological functions rather than accumulating in soft tissues where it could potentially contribute to unwanted calcification.\nMagnesium Bisglycinate: The Gentle Magnesium Choice\nMagnesium Bisglycinate, also known as magnesium glycinate, stands as one of the most bioavailable and well-tolerated forms of magnesium supplementation. This chelated form, where magnesium is bound to two molecules of the amino acid glycine, offers exceptional absorption rates approaching 80-90% while minimizing the gastrointestinal side effects—particularly diarrhea—commonly associated with other magnesium forms like magnesium oxide or sulfate.\nMagnesium plays over 300 enzymatic roles throughout the body, making it indispensable for energy production, protein synthesis, muscle and nerve function, blood glucose control, and blood pressure regulation. Within FABRICAL MG K₂7, magnesium works synergistically with calcium, maintaining the critical calcium-magnesium balance essential for proper muscular contraction and relaxation, cardiovascular rhythm stability, and skeletal mineralization.\nVitamin D3: The Sunshine Vitamin in Its Active Form\nVitamin D3 (cholecalciferol) represents the most bioactive form of vitamin D, identical to what human skin synthesizes upon ultraviolet B exposure. This fat-soluble vitamin functions more accurately as a hormone, regulating calcium absorption from the intestines, maintaining serum calcium and phosphorus concentrations within optimal ranges, and modulating bone remodeling by both osteoblasts and osteoclasts.\nBeyond skeletal functions, Vitamin D3 exerts profound influences on immune system regulation, cellular differentiation and proliferation, neuromuscular function, and inflammation modulation. Vitamin D receptors exist throughout the body—in tissues ranging from the brain and heart to immune cells and muscle—highlighting its systemic importance. The inclusion of Vitamin D3 in FABRICAL MG K₂7 ensures that supplemented calcium can be effectively absorbed and utilized, preventing the futility of calcium supplementation in vitamin D-deficient states.\nVitamin K2-7: The Missing Link in Bone and Cardiovascular Health\nVitamin K2-7, specifically the menaquinone-7 (MK-7) form, represents perhaps the most revolutionary component of FABRICAL MG K₂7. This long-chain vitamin K2 demonstrates superior bioavailability and longer half-life compared to vitamin K1 (phylloquinone) found in green vegetables or shorter-chain K2 forms. Vitamin K2-7's critical function involves activating proteins responsible for proper calcium utilization—specifically matrix Gla protein (MGP) and osteocalcin.\nOsteocalcin, produced by bone-building osteoblasts, requires vitamin K2-dependent carboxylation to become active and effectively bind calcium into bone matrix, strengthening skeletal structure. Simultaneously, Vitamin K2-7 activates MGP, which prevents calcium deposition in arterial walls and soft tissues, directing calcium away from cardiovascular structures where it contributes to atherosclerosis and arterial stiffness. This dual action—promoting bone calcification while preventing vascular calcification—makes Vitamin K2-7 uniquely valuable, addressing the “calcium paradox” where individuals may simultaneously experience osteoporosis and arterial calcification.\nZinc: The Multifunctional Essential Mineral\nZinc, incorporated into FABRICAL MG K₂7 in highly bioavailable form, serves numerous critical physiological functions spanning immune competence, wound healing, protein synthesis, DNA synthesis, and cellular division. Regarding bone health specifically, zinc influences bone metabolism by supporting osteoblast activity and collagen synthesis, contributing to bone matrix formation and mineralization. Zinc also functions as a cofactor for alkaline phosphatase, an enzyme essential for bone mineralization.\nBeyond skeletal contributions, zinc supports immune system function, acting as a critical component of innumerable enzymes involved in immune cell development and function. Zinc deficiency impairs both innate and adaptive immunity, increasing susceptibility to infections. The mineral also supports sensory function (taste and smell), cognitive function, reproductive health, and skin integrity.\nMethylcobalamin: The Bioactive Vitamin B12\nMethylcobalamin represents the active, coenzyme form of vitamin B12, requiring no metabolic conversion to exert biological activity. This form demonstrates superior neurological benefits compared to cyanocobalamin, the synthetic form commonly used in supplements. Methylcobalamin directly participates in methionine synthesis and methylation reactions critical for nervous system health, DNA synthesis, red blood cell formation, and homocysteine metabolism.\nElevated homocysteine, resulting from inadequate B12 status, associates with increased cardiovascular disease risk, cognitive decline, and bone fragility. By supporting homocysteine conversion to methionine, methylcobalamin in FABRICAL MG K₂7 contributes to cardiovascular protection and potentially supports bone health through mechanisms independent of its well-established neurological and hematological roles.\nPrimary Uses and Clinical Applications of FABRICAL MG K₂7\nComprehensive Bone Health Support\nThe primary indication for FABRICAL MG K₂7 centers on comprehensive bone health support across various life stages and clinical scenarios. The formulation addresses all critical aspects of skeletal health: providing adequate calcium substrate for mineralization, ensuring calcium absorption through Vitamin D3, directing calcium into bone matrix via Vitamin K2-7, supporting bone matrix formation through magnesium and zinc, and protecting against homocysteine-related bone fragility through methylcobalamin.\nThis makes FABRICAL MG K₂7 particularly valuable for:\nOsteoporosis Prevention and Management: Postmenopausal women and elderly men experiencing age-related bone loss benefit from the formulation's comprehensive approach, potentially slowing bone density decline and reducing fracture risk.\nGrowing Children and Adolescents: During peak bone-building years, FABRICAL MG K₂7 supports optimal skeletal development, helping children and teenagers achieve maximum peak bone mass—a critical determinant of lifelong skeletal health.\nPregnancy and Lactation: Women during pregnancy and breastfeeding experience dramatically increased calcium demands. FABRICAL MG K₂7 helps prevent maternal bone density loss while supporting fetal skeletal development.\nCardiovascular Protection Through Proper Calcium Distribution\nThe Vitamin K2-7 component positions FABRICAL MG K₂7 as more than a bone health supplement—it's a cardiovascular protective formulation. By activating matrix Gla protein, the supplement helps prevent arterial calcification, potentially reducing cardiovascular disease risk. This dual benefit addresses the concerning observation that some individuals taking calcium supplements without adequate Vitamin K2 may experience increased cardiovascular events due to inappropriate calcium deposition in arterial walls.\nNeurological and Cognitive Support\nThe methylcobalamin component provides neurological support, particularly valuable for elderly individuals at risk for vitamin B12 deficiency due to reduced intrinsic factor production or those taking medications that impair B12 absorption (such as metformin or proton pump inhibitors). Adequate B12 status supports cognitive function, mood regulation, nerve conduction, and may help prevent peripheral neuropathy.\nImmune System Enhancement\nBoth zinc and vitamin D3 within FABRICAL MG K₂7 contribute significantly to immune competence. Vitamin D modulates both innate and adaptive immunity, while zinc supports immune cell development and function. This immune support proves particularly relevant during seasonal illness peaks or for individuals with compromised immunity.\nMuscle Function and Exercise Performance\nMagnesium's role in muscle contraction and relaxation, combined with calcium's involvement in excitation-contraction coupling, makes FABRICAL MG K₂7 valuable for athletes and physically active individuals. The formulation may help prevent exercise-associated muscle cramps, support recovery, and maintain electrolyte balance.\nKey Benefits of FABRICAL MG K₂7\nEnhanced Bioavailability and Absorption\nUnlike basic supplements using inferior ingredient forms, FABRICAL MG K₂7 utilizes premium, highly bioavailable compounds:\n\nCalcium Citrate Maleate offers superior absorption compared to calcium carbonate\nMagnesium Bisglycinate provides excellent absorption without gastrointestinal distress\nVitamin D3 is more potent than D2\nVitamin K2-7 (MK-7) has longer half-life and better tissue distribution than K1 or shorter-chain K2 forms\nMethylcobalamin is the active B12 form requiring no conversion\n\nThis superior bioavailability means lower doses can achieve therapeutic effects, reducing pill burden and potential adverse effects while maximizing benefits.\nSynergistic Nutrient Interactions\nFABRICAL MG K₂7's formulation recognizes that nutrients work together, not in isolation:\n\nVitamin D3 enhances calcium absorption while Vitamin K2-7 directs where that calcium goes\nMagnesium supports Vitamin D activation and calcium metabolism\nZinc supports bone matrix formation complementing calcium's role in mineralization\nMethylcobalamin supports methylation pathways that may influence bone health\n\nThis synergy delivers benefits exceeding what individual nutrients could provide separately.\nComprehensive Rather Than Fragmented Nutritional Support\nRather than requiring multiple separate supplements, FABRICAL MG K₂7 provides comprehensive support in a single, convenient formulation. This simplification improves compliance, reduces costs compared to purchasing individual supplements, and eliminates concerns about nutrient imbalances from uncoordinated supplementation.\nProtection Against the Calcium Paradox\nPerhaps the most significant benefit stems from the Vitamin K2-7 inclusion, which addresses the calcium paradox—simultaneously strengthening bones while protecting cardiovascular health by preventing arterial calcification. This represents a critical advancement over traditional calcium supplements that may inadvertently increase cardiovascular risk when taken without adequate Vitamin K2.\nSupport Across Multiple Physiological Systems\nBeyond bones, FABRICAL MG K₂7 benefits:\n\nCardiovascular System: Through arterial protection and homocysteine management\nNervous System: Via methylcobalamin's neurological support\nImmune System: Through vitamin D3 and zinc's immunomodulatory effects\nMuscular System: Via magnesium and calcium's roles in contraction\nMetabolic System: Through magnesium's involvement in glucose metabolism\n\nThis multi-system support delivers value far exceeding simple bone health supplementation.\nPotential Side Effects and Safety Considerations\nGenerally Well-Tolerated with Minimal Side Effects\nFABRICAL MG K₂7, when taken as directed, demonstrates excellent tolerability in most individuals. The selection of highly bioavailable, gentle nutrient forms specifically minimizes adverse effects common with inferior formulations.\nMild Gastrointestinal Effects\nSome users may initially experience mild digestive symptoms including:\n\nSlight nausea, particularly if taken on an empty stomach\nMinor bloating or gas\nMild constipation (though less likely than with calcium carbonate formulations)\n\nThese effects typically resolve within a few days as the body adjusts and can be minimized by taking the supplement with meals and ensuring adequate hydration.\nRare Allergic Reactions\nAlthough uncommon, some individuals may experience hypersensitivity to ingredients or excipients in the formulation. Signs include rash, itching, or swelling. Discontinuation and medical consultation are warranted if such reactions occur.\nConsiderations for Specific Populations\nIndividuals on Anticoagulants: Vitamin K2, while generally safer regarding coagulation than K1, may theoretically interact with warfarin. Patients on anticoagulation therapy should consult healthcare providers before starting FABRICAL MG K₂7, though recent evidence suggests K2 supplementation at consistent doses may not significantly affect INR stability.\nKidney Disease Patients: Individuals with chronic kidney disease should consult nephrologists before supplementing with calcium, magnesium, or vitamin D due to altered mineral metabolism and increased calcification risks in renal impairment.\nHypercalcemia Risk: Those with conditions predisposing to elevated calcium (hyperparathyroidism, sarcoidosis, certain cancers) should avoid supplementation without medical supervision.\nImportance of Appropriate Dosing\nExceeding recommended doses may increase adverse effect risks including:\n\nHypercalcemia (excessive calcium) causing nausea, constipation, kidney stones\nHypermagnesemia (excessive magnesium) causing diarrhea, cardiac abnormalities\nVitamin D toxicity (though requiring very high doses sustained over time)\n\nFollowing manufacturer's recommendations and consulting healthcare providers regarding individual needs ensures safe, effective use.\nRecommended Usage and Dosage Guidelines\nFABRICAL MG K₂7 should be taken according to manufacturer recommendations, typically one to two tablets daily with meals for optimal absorption of fat-soluble vitamins (D3 and K2-7). Taking the supplement with food containing some dietary fat further enhances absorption of these critical nutrients while minimizing potential gastrointestinal discomfort.\nConsistency in timing supports optimal benefits, as regular daily supplementation maintains stable nutrient levels. For individuals on multiple medications, spacing FABRICAL MG K₂7 administration at least two hours from certain medications (particularly thyroid hormones, bisphosphonates, or antibiotics) prevents potential absorption interference.\nIndividual requirements vary based on age, sex, dietary intake, health status, and specific deficiency risks. Healthcare provider consultation helps determine whether standard dosing suffices or whether adjustments are warranted. Periodic monitoring of vitamin D levels and other relevant biomarkers may be recommended to ensure supplementation achieves therapeutic goals without overshooting into excess.\nConclusion: FABRICAL MG K₂7 as a Comprehensive Nutritional Solution\nFABRICAL MG K₂7 stands as a sophisticated, scientifically formulated nutritional supplement that transcends traditional approaches to bone health support. By combining six synergistic nutrients in highly bioavailable forms, this innovative product addresses the complex, interconnected nature of skeletal health, cardiovascular protection, neurological function, and overall metabolic wellness.\nThe formulation's greatest strength lies in its comprehensive approach—recognizing that optimal health outcomes require balanced nutrition rather than isolated nutrient provision. The inclusion of Vitamin K2-7 particularly distinguishes FABRICAL MG K₂7 from conventional calcium supplements, addressing the critical calcium paradox and ensuring supplemented calcium strengthens bones while protecting cardiovascular structures.\nFor individuals seeking to support bone density, prevent osteoporosis, ensure adequate nutritional status during life stages of increased demand, or simply maintain optimal health through evidence-based supplementation, FABRICAL MG K₂7 offers a convenient, effective solution backed by nutritional science. Its excellent tolerability, superior ingredient quality, and multi-system benefits make it suitable for diverse populations from growing adolescents to active adults and elderly individuals concerned about age-related health challenges.\nAs with any nutritional supplement, FABRICAL MG K₂7 works best as part of a comprehensive health strategy including balanced nutrition, regular physical activity, adequate sleep, stress management, and appropriate medical care. It complements rather than replaces healthy lifestyle practices, providing nutritional insurance that helps fill gaps in modern diets while supporting long-term wellness.\nWhether you're proactively supporting your skeletal health, addressing identified nutritional deficiencies, or seeking comprehensive multi-nutrient support, FABRICAL MG K₂7 represents a premium choice that combines scientific sophistication with practical convenience, delivering measurable benefits that support vibrant health across all life stages.\n\nDisclaimer: This information is for educational purposes and does not constitute medical advice. Individual nutritional needs vary significantly based on numerous factors. Consult qualified healthcare professionals before starting any supplement regimen, particularly if you have existing health conditions, take medications, are pregnant or nursing, or have specific health concerns. Keep supplements out of reach of children and store according to manufacturer recommendations to maintain product integrity and safety.", "price": 250.0, "discountamount": 75.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2274, "imageuri": "https://productimages.withfloats.com/actual/696621081f531945cbd90a0c.png", "tileimageuri": "https://productimages.withfloats.com/tile/696621081f531945cbd90a0c.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-01-13T10:40:01.051Z", "updatedon": "2026-02-13T07:27:00.217Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/fabrical-mg-k-7/2274", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "FABRICAL MG K₂7", "category": "ORTHOLOGYRANG", "tags": [ "calcium citrate maleate magnesium bisglycinate tablets", "calcium citrate maleate with vitamin d3 k2 mk7", "magnesium bisglycinate with methylcobalamin tablets", "calcium citrate maleate vitamin k2-7 tablets", "best calcium citrate maleate tablets for bones", "magnesium bisglycinate tablets for muscle cramps", "methylcobalamin zinc tablets for nerve health", "calcium citrate maleate tablets for osteoporosis", "best calcium supplement with k2-7 for bone strength", "vitamin k2-7 mk7 with calcium benefits", "bone strength tablets with calcium magnesium zinc", "vitamin d3 k2 calcium tablets for elderly", "calcium citrate maleate tablets price in india", "best calcium magnesium vitamin d3 k2 tablets", "best bone health tablets with vitamin k2-7", "calcium magnesium zinc methylcobalamin tablets" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "695b65af2800555f6696a6cf", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Cinacalcet 60 mg Tablet", "description": "CINASELECT 60: Comprehensive Guide to Cinacalcet 60 mg Tablets\nProduct Overview\nCINASELECT 60 is a pharmaceutical formulation containing Cinacalcet hydrochloride 60 mg as its active ingredient. This medication represents a significant advancement in the management of calcium metabolism disorders, particularly in patients with chronic kidney disease and parathyroid conditions. As a calcimimetic agent, CINASELECT 60 works by mimicking the action of calcium on tissues, helping to restore hormonal balance and mineral homeostasis in the body.\nThe 60 mg dosage strength offers an effective therapeutic option for patients requiring moderate to higher-level intervention in managing parathyroid hormone levels and associated calcium imbalances. CINASELECT 60 is manufactured under strict quality control standards, ensuring consistency, purity, and efficacy in every tablet.\nUnderstanding How CINASELECT 60 Works\nCINASELECT 60 operates through a sophisticated mechanism that targets the calcium-sensing receptors located on the surface of parathyroid gland cells. These receptors play a crucial role in regulating parathyroid hormone secretion, which in turn controls calcium and phosphorus levels in the bloodstream.\nWhen you take CINASELECT 60, the active ingredient cinacalcet binds to these calcium-sensing receptors, increasing their sensitivity to extracellular calcium. This enhanced sensitivity tricks the parathyroid glands into “thinking” there is more calcium present in the blood than there actually is. As a result, the glands reduce their production and release of parathyroid hormone (PTH).\nBy lowering PTH levels, CINASELECT 60 subsequently reduces calcium levels in the blood and decreases the amount of phosphorus absorbed from the intestines. This cascade effect helps restore the delicate mineral balance that is often disrupted in patients with kidney disease or parathyroid disorders.\nPrimary Therapeutic Uses\nSecondary Hyperparathyroidism in Chronic Kidney Disease\nThe primary indication for CINASELECT 60 is the treatment of secondary hyperparathyroidism in adult patients with chronic kidney disease (CKD) who are on dialysis. When kidneys fail to function properly, they cannot adequately regulate calcium and phosphorus levels, leading to excessive parathyroid hormone production. This condition can result in serious complications including bone disease, cardiovascular calcification, and increased mortality risk.\nCINASELECT 60 helps manage this condition by controlling PTH levels, thereby reducing the risk of bone complications such as osteitis fibrosa cystica and preventing the dangerous deposition of calcium in blood vessels and soft tissues.\nHypercalcemia in Parathyroid Carcinoma\nCINASELECT 60 is also indicated for treating hypercalcemia (elevated blood calcium levels) in patients with parathyroid carcinoma, a rare malignant tumor of the parathyroid glands. In these cases, the medication helps control the dangerously high calcium levels that can lead to kidney stones, bone pain, digestive issues, and neurological symptoms.\nPrimary Hyperparathyroidism\nFor patients with severe hypercalcemia due to primary hyperparathyroidism who cannot undergo parathyroidectomy or for whom surgery has failed, CINASELECT 60 offers a valuable medical management option. This provides relief for patients who are not surgical candidates due to advanced age, comorbidities, or other contraindications.\nKey Benefits of CINASELECT 60\nEffective PTH Control\nClinical studies have demonstrated that CINASELECT 60 significantly reduces parathyroid hormone levels in a dose-dependent manner. This reduction helps prevent the cascade of complications associated with elevated PTH, including bone mineral loss and cardiovascular calcification.\nImproved Calcium-Phosphorus Balance\nBy reducing PTH secretion, CINASELECT 60 helps normalize serum calcium and phosphorus levels. This is particularly important in dialysis patients, where mineral imbalances can lead to serious complications affecting bone health, cardiovascular function, and overall quality of life.\nReduced Cardiovascular Risk\nElevated calcium and phosphorus levels contribute to vascular calcification, a major risk factor for cardiovascular disease in patients with chronic kidney disease. By managing these mineral levels, CINASELECT 60 may help reduce the risk of cardiovascular complications, which are the leading cause of death in dialysis patients.\nBone Health Preservation\nUncontrolled secondary hyperparathyroidism leads to renal osteodystrophy, a condition characterized by abnormal bone metabolism. CINASELECT 60 helps protect bone integrity by normalizing PTH levels, potentially reducing fracture risk and preserving bone mineral density.\nAlternative to Surgery\nFor patients with primary hyperparathyroidism or parathyroid carcinoma who cannot undergo surgery, CINASELECT 60 provides an effective medical management option. This is particularly valuable for elderly patients or those with multiple comorbidities that make surgery risky.\nQuality of Life Improvement\nBy controlling symptoms associated with hypercalcemia and hyperparathyroidism, such as bone pain, muscle weakness, fatigue, and digestive issues, CINASELECT 60 can significantly improve patients' overall quality of life and functional capacity.\nConvenient Oral Administration\nCINASELECT 60 is administered orally, making it more convenient than injectable alternatives. This allows for outpatient management and reduces the burden on healthcare facilities and patients.\nPotential Side Effects and Adverse Reactions\nCommon Side Effects\nPatients taking CINASELECT 60 may experience several common side effects, which typically include nausea and vomiting, occurring in approximately 20-30% of patients. These gastrointestinal symptoms are usually mild to moderate and may improve over time as the body adjusts to the medication.\nDiarrhea is another frequent complaint, affecting roughly 20% of users. Some patients also report muscle pain or myalgia, dizziness, loss of appetite, and asthenia (general weakness or fatigue).\nSerious Side Effects Requiring Medical Attention\nHypocalcemia: The most significant risk associated with CINASELECT 60 is the development of low calcium levels in the blood. Severe hypocalcemia can lead to paresthesias (tingling sensations), muscle cramps or spasms, tetany, seizures, and QT interval prolongation on electrocardiogram, which can predispose to dangerous heart rhythm abnormalities.\nGastrointestinal Bleeding: There have been reports of gastrointestinal hemorrhage in patients taking cinacalcet, particularly in those with risk factors such as gastritis, ulcers, or concurrent use of other medications that increase bleeding risk.\nAdynamic Bone Disease: Oversuppression of PTH can lead to adynamic bone disease, a condition where bone turnover becomes abnormally low, potentially weakening bones despite normalized calcium levels.\nCardiovascular Effects: Some patients may experience worsening heart failure or arrhythmias, particularly if hypocalcemia develops. Close monitoring is essential in patients with underlying cardiovascular disease.\nAllergic Reactions: Though rare, hypersensitivity reactions including rash, urticaria, and angioedema have been reported.\nPrecautions and Contraindications\nCINASELECT 60 should not be used in patients with serum calcium levels below the normal range. It requires careful dose adjustment and monitoring in patients with hepatic impairment. The medication may interact with drugs metabolized by the CYP2D6 enzyme system and with medications that affect gastric pH.\nPregnant or breastfeeding women should use CINASELECT 60 only if clearly needed, as its safety in these populations has not been fully established. Regular monitoring of serum calcium, phosphorus, and PTH levels is essential throughout treatment.\nDosage and Administration Guidelines\nCINASELECT 60 should be taken orally with food or shortly after a meal, as this improves absorption and reduces gastrointestinal side effects. Tablets should be swallowed whole and not crushed, chewed, or divided.\nThe typical starting dose for secondary hyperparathyroidism is lower than 60 mg, with gradual titration based on PTH and calcium levels. The 60 mg strength is often used as part of the dose escalation process or as a maintenance dose once optimal PTH control is achieved.\nDose adjustments should be made no more frequently than every two to four weeks, as it takes this long to see the full effect of a dose change on PTH levels. Treatment should be individualized based on laboratory values and clinical response.\nMonitoring Requirements\nPatients on CINASELECT 60 require regular monitoring of serum calcium, phosphorus, and intact PTH levels. Calcium levels should be checked within one week of starting treatment or after any dose adjustment, and then monthly once stable. PTH levels should be measured one to four weeks after initiation or dose adjustment, then every one to three months during maintenance therapy.\nAdditionally, patients should be monitored for signs and symptoms of hypocalcemia, particularly during the initial treatment period. Electrocardiogram monitoring may be appropriate in patients at risk for QT prolongation.\nStorage and Handling\nCINASELECT 60 should be stored at room temperature, away from moisture and direct sunlight. The medication should be kept in its original container with the lid tightly closed to protect from humidity. Keep out of reach of children and pets. Do not use past the expiration date printed on the package.\nConclusion\nCINASELECT 60 (Cinacalcet 60 mg) represents a valuable therapeutic option in the management of secondary hyperparathyroidism associated with chronic kidney disease, hypercalcemia in parathyroid carcinoma, and primary hyperparathyroidism in patients who cannot undergo surgery. Its unique mechanism as a calcimimetic agent provides effective control of parathyroid hormone secretion, helping to restore mineral balance and prevent serious complications.\nThe benefits of CINASELECT 60 extend beyond simple laboratory value normalization. By controlling PTH, calcium, and phosphorus levels, this medication helps preserve bone health, reduce cardiovascular calcification risk, and improve overall quality of life for patients dealing with complex metabolic disorders. For patients who are not surgical candidates, CINASELECT 60 offers hope and effective symptom management.\nHowever, like all medications, CINASELECT 60 must be used judiciously under close medical supervision. The risk of hypocalcemia and other potential side effects necessitates regular laboratory monitoring and open communication between patients and healthcare providers. Patients should report any concerning symptoms promptly and attend all scheduled follow-up appointments.", "price": 740.0, "discountamount": 222.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2266, "imageuri": "https://productimages.withfloats.com/actual/695b65ebf30763183f64d4f7.png", "tileimageuri": "https://productimages.withfloats.com/tile/695b65ebf30763183f64d4f7.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-01-05T07:18:07.264Z", "updatedon": "2026-01-05T11:40:04.861Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/cinacalcet-60-mg-tablet/2266", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CINASELECT 60", "category": "NEPHROLOGYRANGE", "tags": [ "cinacalcet 60 mg", "cinacalcet 60 mg tablet", "cinacalcet 60 mg price", "cinacalcet 60 mg tab", "cinacalcet mechanism of action.", "cinacalcet uses", "tab cinacalcet.", "cinacalcet dose.", "cinacalcet structure.", "cinacalcet tab.", "calcium and phosphorus levels in the bloodstream.", "parathyroid hormone secretion.", "calcium metabolism disorders.", "chronic kidney disease and parathyroid conditions." ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6958f0362c7664595f507382", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Atrovastatin Calcium 10mg, Fenofibrate 160mg, Ezetimibe IP 10mg", "description": "In today’s fast-paced lifestyle, heart health has become a growing concern across all age groups. Sedentary habits, high-fat diets, stress, smoking, diabetes, and genetic factors have significantly increased the prevalence of abnormal cholesterol and lipid levels. Conditions such as high LDL cholesterol, elevated triglycerides, and mixed dyslipidemia are now among the leading risk factors for heart attacks, strokes, and other cardiovascular complications.\n\nATOVASTRIN EZ F is a scientifically formulated combination therapy designed to address these complex lipid abnormalities from multiple angles. It brings together three well-established lipid-lowering agents—Atorvastatin Calcium, Fenofibrate, and Ezetimibe—to provide comprehensive control over cholesterol and triglyceride levels.\n\nRather than targeting only one pathway, ATOVASTRIN EZ F works holistically to reduce bad cholesterol, control triglycerides, improve good cholesterol levels, and lower overall cardiovascular risk. It is particularly beneficial for patients who do not achieve adequate lipid control with single-drug therapy.\n\nComposition\n\nEach tablet of ATOVASTRIN EZ F contains:\n\nAtorvastatin Calcium 10 mg\n\nFenofibrate 160 mg\n\nEzetimibe IP 10 mg\n\nThis balanced combination allows effective lipid management with a single daily dose, improving patient compliance and long-term outcomes.\n\nHow ATOVASTRIN EZ F Works\n\nATOVASTRIN EZ F works through three complementary mechanisms that together provide superior lipid control.\n\nAtorvastatin Calcium\n\nAtorvastatin belongs to the statin class of drugs. It works by inhibiting HMG-CoA reductase, an enzyme responsible for cholesterol production in the liver. This leads to:\n\nReduced LDL (bad cholesterol)\n\nModerate increase in HDL (good cholesterol)\n\nLower total cholesterol levels\n\nFenofibrate\n\nFenofibrate primarily targets triglycerides. It activates specific receptors that enhance fat breakdown and clearance from the blood. Its benefits include:\n\nSignificant reduction in triglyceride levels\n\nIncrease in HDL cholesterol\n\nImprovement in lipid particle size and quality\n\nEzetimibe\n\nEzetimibe works in the intestine by blocking cholesterol absorption from food and bile. This reduces the amount of cholesterol entering the bloodstream, further enhancing lipid control when combined with statins.\n\nTogether, these three components make ATOVASTRIN EZ F a powerful option for managing complex and resistant lipid disorders.\n\nUses of ATOVASTRIN EZ F\n1. Mixed Dyslipidemia\n\nATOVASTRIN EZ F is widely used in patients with both high cholesterol and high triglycerides, where monotherapy is often insufficient.\n\n2. Hypercholesterolemia\n\nIt helps reduce elevated LDL and total cholesterol levels, especially in patients at high cardiovascular risk.\n\n3. Hypertriglyceridemia\n\nThe presence of Fenofibrate makes this combination highly effective in lowering triglyceride levels.\n\n4. Cardiovascular Risk Reduction\n\nBy improving lipid profiles, ATOVASTRIN EZ F helps reduce the risk of heart attacks, strokes, and atherosclerosis.\n\n5. Diabetic Dyslipidemia\n\nPatients with diabetes often suffer from abnormal lipid patterns. This combination offers comprehensive lipid control in such cases.\n\nKey Benefits of ATOVASTRIN EZ F\n1. Comprehensive Lipid Control\n\nATOVASTRIN EZ F addresses all major lipid parameters—LDL, triglycerides, total cholesterol, and HDL—in one formulation.\n\n2. Reduces Bad Cholesterol (LDL)\n\nAtorvastatin and Ezetimibe work together to significantly lower LDL cholesterol, a major cause of arterial blockage.\n\n3. Lowers Triglycerides Effectively\n\nFenofibrate plays a crucial role in controlling high triglyceride levels, which are linked to pancreatitis and heart disease.\n\n4. Improves Good Cholesterol (HDL)\n\nBy increasing HDL levels, ATOVASTRIN EZ F supports the removal of excess cholesterol from blood vessels.\n\n5. Prevents Plaque Formation\n\nConsistent lipid control helps slow down or prevent the buildup of fatty plaques in arteries.\n\n6. Supports Long-Term Heart Health\n\nRegular use, along with lifestyle changes, helps maintain cardiovascular health and reduces future complications.\n\n7. Convenient Once-Daily Therapy\n\nA single tablet simplifies treatment, improving patient adherence and consistency.\n\nDosage and Administration\n\nThe usual recommended dose is one tablet once daily, or as directed by the physician.\n\nIt is generally taken after food to minimize stomach discomfort.\n\nRegular follow-ups and blood tests may be advised to monitor lipid levels and liver function.\n\nNote: Dosage adjustments should only be made under medical supervision.\n\nPossible Side Effects of ATOVASTRIN EZ F\n\nMost patients tolerate ATOVASTRIN EZ F well. However, like all medicines, it may cause side effects in some individuals.\n\nCommon Side Effects\n\nMild stomach upset\n\nNausea\n\nIndigestion\n\nHeadache\n\nMuscle discomfort\n\nLess Common Side Effects\n\nElevated liver enzymes\n\nMuscle pain or weakness\n\nFatigue\n\nDizziness\n\nRare but Serious Side Effects\n\nSevere muscle problems (myopathy or rhabdomyolysis)\n\nLiver function abnormalities\n\nAllergic reactions\n\nPatients should immediately report unexplained muscle pain, weakness, or dark-colored urine to their healthcare provider.\n\nPrecautions and Warnings\n\nLiver Disorders: Patients with liver disease should use ATOVASTRIN EZ F cautiously.\n\nKidney Problems: Fenofibrate requires careful monitoring in kidney impairment.\n\nPregnancy and Breastfeeding: Not recommended due to potential risk to the fetus or infant.\n\nAlcohol Consumption: Excessive alcohol intake should be avoided.\n\nDrug Interactions: Inform your doctor about all medicines, supplements, or herbal products you are taking.\n\nLifestyle Recommendations Alongside Therapy\n\nFor best results, ATOVASTRIN EZ F should be combined with:\n\nA low-fat, heart-healthy diet\n\nRegular physical activity\n\nWeight management\n\nSmoking cessation\n\nStress control\n\nMedication works best when supported by healthy lifestyle choices.\n\nStorage Instructions\n\nStore in a cool, dry place\n\nProtect from moisture and direct sunlight\n\nKeep out of reach of children\n\nDo not use after the expiry date\n\nConclusion\nATOVASTRIN EZ F is a thoughtfully designed triple-combination therapy that offers comprehensive lipid management for patients with complex cholesterol disorders. By combining the proven benefits of Atorvastatin Calcium, Fenofibrate, and Ezetimibe, it addresses multiple causes of dyslipidemia in a single, convenient tablet.", "price": 280.0, "discountamount": 84.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2264, "imageuri": "https://productimages.withfloats.com/actual/6958f0e4d45a48ed959ecc5a.png", "tileimageuri": "https://productimages.withfloats.com/tile/6958f0e4d45a48ed959ecc5a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-01-03T10:32:22.384Z", "updatedon": "2026-01-08T07:47:43.928Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/atrovastatin-calcium-10mg-fenofibrate-160mg-ezetimibe-ip-10mg/2264", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ATOVASTRIN EZ F", "category": "CARDIOLOGYRANGE", "tags": [ "atrovastatin 10mg", "atorvastatin 10mg and fenofibrate 160mg", "atorvastatin 10mg fenofibrate 160mg tab", "fenofibrate 160mg tab", "atorvastatin 10mg + fenofibrate 160mg", "heart attacks.", "LDL cholesterol.", "cardiovascular complications.", "Atorvastatin Calcium, Fenofibrate, and Ezetimibe.", "cholesterol and triglyceride levels.", "lipid control with single-drug therapy.", "Reduced LDL bad cholesterol", "ATOVASTRIN EZ F", "atorvastatin calcium fenofibrate ezetimibe tablets", "atorvastatin fenofibrate ezetimibe combination tablet", "atorvastatin calcium fenofibrate 160 ezetimibe 10 mg tablets", "triple combination cholesterol tablet atorvastatin fenofibrate ezetimibe", "atorvastatin fenofibrate ezetimibe medicine for cholesterol", "atorvastatin fenofibrate ezetimibe fixed dose combination", "what is atorvastatin fenofibrate ezetimibe tablet used for", "how does atorvastatin fenofibrate ezetimibe work", "benefits of atorvastatin fenofibrate ezetimibe tablets", "side effects of atorvastatin fenofibrate ezetimibe", "who should take atorvastatin fenofibrate ezetimibe tablets", "is atorvastatin fenofibrate ezetimibe safe for long term use" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }